Last $0.0001 USD
Change Today 0.00 / 0.00%
Volume 0.0
IPAH On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 09/3/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Maganlal K. Sutaria M.D.

AgeTotal Calculated CompensationThis person is connected to 156 board members in 2 different organizations across 2 different industries.

See Board Relationships
78--

Background*

Dr. Maganlal K. Sutaria, M.D., was the Chief Executive Officer of Interpharm Holdings Inc. until January 25, 2005. Dr. Sutaria is the Chairman of the Board and Director at Interpharm Holdings, Inc. since May 29, 2003. Dr. Sutaria serves as Trustee of North Shore - Long Island Jewish Health System, Inc. Dr. Sutaria has served as an Assistant Professor of Surgery at the State University of New York at Stony Brook. He received his medical degree from the Medical College, ...

Read Full Background

Corporate Headquarters*

75 Adams Avenue
Hauppauge, New York 11788

United States

Phone: 631-952-0214
Fax: 631-952-9587

Board Members Memberships*

Trustee
2003-Present
Chairman

Education*

MD 1961
B. J. Medical College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IPAH:US $0.00 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Rajat Rai Chief Executive Officer
Akorn, Inc.
$250.0K
Craig A. Wheeler Chief Executive Officer, President and Executive Director
Momenta Pharmaceuticals Inc.
$621.0K
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Douglas L. Drysdale Chairman, Chief Executive Officer and President
Pernix Therapeutics Holdings, Inc.
--
Jeffrey M. Yordon Founder, Chairman and Chief Executive Officer
Sagent Pharmaceuticals, Inc.
$615.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTERPHARM HOLDINGS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.